{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:06:40Z","timestamp":1791331600136,"version":"4.3.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:00:00Z","timestamp":1706313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.lungcan.2024.107496","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T11:32:45Z","timestamp":1706527965000},"page":"107496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients"],"prefix":"10.1016","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6709-9135","authenticated-orcid":false,"given":"Linus D.","family":"Kloker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Sidiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2729-9941","authenticated-orcid":false,"given":"Tim","family":"Flaadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines B.","family":"Brecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1961-9382","authenticated-orcid":false,"given":"Christoph K.W.","family":"Deinzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorben","family":"Gro\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Benzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Zender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich M.","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lungcan.2024.107496_b0005","doi-asserted-by":"crossref","first-page":"p. pkz094","DOI":"10.1093\/jncics\/pkz094","article-title":"An anatomical site and genetic-based prognostic model for patients with nuclear protein in testis (NUT) midline carcinoma: analysis of 124 patients","volume":"4","author":"Chau","year":"2020","journal-title":"JNCI Cancer Spectr"},{"issue":"6","key":"10.1016\/j.lungcan.2024.107496_b0010","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41379-019-0206-z","article-title":"NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum","volume":"32","author":"Stevens","year":"2019","journal-title":"Mod. Pathol."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107496_b0015","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00405-018-4882-y","article-title":"Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases","volume":"275","author":"Giridhar","year":"2018","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.lungcan.2024.107496_b0020","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-22-0591","article-title":"Report of the first international symposium on NUT carcinoma","author":"French","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2024.107496_b0025","doi-asserted-by":"crossref","first-page":"e2200633","DOI":"10.1200\/PO.22.00633","article-title":"Exceptional response to bromodomain and extraterminal domain inhibitor therapy with BMS-986158 in BRD4-NUTM1 NUT carcinoma harboring a BRD4 splice site mutation","volume":"7","author":"Cheng","year":"2023","journal-title":"JCO Precis. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2024.107496_b0030","doi-asserted-by":"crossref","first-page":"e665","DOI":"10.1016\/j.cllc.2020.10.016","article-title":"Prolonged disease control on nivolumab for primary pulmonary NUT carcinoma","volume":"22","author":"Davis","year":"2021","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.lungcan.2024.107496_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.995744","article-title":"Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinoma","volume":"12","author":"Kloker","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2024.107496_b0040","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/ijc.33861","article-title":"Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein in testis carcinoma and other cancers: Results of a Phase I\/II open-label, dose escalation study","volume":"150","author":"Cousin","year":"2022","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2024.107496_b0045","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41416-020-01180-1","article-title":"A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma","volume":"124","author":"Shapiro","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2024.107496_b0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/MPH.0000000000002568","article-title":"NUT carcinoma in children and adolescents: the expert European standard clinical practice harmonized recommendations","volume":"45","author":"Lemelle","year":"2023","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107496_b0055","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/annonc\/mdw686","article-title":"Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma","volume":"28","author":"Lee","year":"2017","journal-title":"Ann. Oncol."},{"issue":"13","key":"10.1016\/j.lungcan.2024.107496_b0060","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/onc.2013.126","article-title":"MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma","volume":"33","author":"Grayson","year":"2014","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.lungcan.2024.107496_b0065","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1158\/0008-5472.CAN-13-2658","article-title":"Activation of SOX2 expression by BRD4-NUT oncogenic fusion drives neoplastic transformation in NUT midline carcinoma","volume":"74","author":"Wang","year":"2014","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.lungcan.2024.107496_b0070","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/s41388-020-01625-0","article-title":"Supercharging BRD4 with NUT in carcinoma","volume":"40","author":"Eagen","year":"2021","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.lungcan.2024.107496_b0075","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1158\/2159-8290.CD-14-0014","article-title":"NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism","volume":"4","author":"French","year":"2014","journal-title":"Cancer Discov."},{"issue":"15","key":"10.1016\/j.lungcan.2024.107496_b0080","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1038\/sj.onc.1210852","article-title":"BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells","volume":"27","author":"French","year":"2008","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.lungcan.2024.107496_b0085","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/PAI.0000000000000781","article-title":"Tumor Mutation burden and checkpoint immunotherapy markers in NUT midline carcinoma","volume":"28","author":"He","year":"2020","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"68","key":"10.1016\/j.lungcan.2024.107496_b0090","doi-asserted-by":"crossref","first-page":"112313","DOI":"10.18632\/oncotarget.22862","article-title":"Molecular-genetic profiling and high-throughput in vitro drug screening in NUT midline carcinoma-an aggressive and fatal disease","volume":"8","author":"Stirnweiss","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lungcan.2024.107496_b0095","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.2147\/CMAR.S199260","article-title":"Prognostic significance of serum lactate dehydrogenase in patients with breast cancer: a meta-analysis","volume":"11","author":"Liu","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107496_b0100","first-page":"46","article-title":"Correlation of lactate dehydrogenase isoenzyme profile with outcome in patients with advanced colorectal cancer treated with chemotherapy and bevacizumab or cediranib: Retrospective analysis of the HORIZON I study","volume":"13","author":"Bar","year":"2014","journal-title":"Clin. Colorectal Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2024.107496_b0105","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3233\/CBM-160580","article-title":"Prognostic significance of serum LDH in small cell lung cancer: A systematic review with meta-analysis","volume":"16","author":"Zhang","year":"2016","journal-title":"Cancer Biomark."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107496_b0110","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/ajcp\/96.4.441","article-title":"Lactic dehydrogenase. An old enzyme reborn as a cancer marker?","volume":"96","author":"Schwartz","year":"1991","journal-title":"Am. J. Clin. Pathol."},{"issue":"14","key":"10.1016\/j.lungcan.2024.107496_b0115","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1200\/JCO.2009.26.2493","article-title":"Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era","volume":"28","author":"Ziepert","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.lungcan.2024.107496_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091243","article-title":"Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker","volume":"11","author":"Pelizzari","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.lungcan.2024.107496_b0125","first-page":"189","article-title":"The utility of lactate dehydrogenase in the follow up of patients with diffuse large B-cell lymphoma","volume":"35","author":"William","year":"2013","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"10.1016\/j.lungcan.2024.107496_b0130","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2147\/CLEP.S415171","article-title":"Prognostic Value of Post-Operative C-Reactive Protein-Based Inflammatory Biomarkers in Colorectal Cancer Patients: Systematic Review and Meta-Analysis","volume":"15","author":"Gwenzi","year":"2023","journal-title":"Clin. Epidemiol."},{"issue":"8","key":"10.1016\/j.lungcan.2024.107496_b0135","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.21037\/tcr-23-1157","article-title":"Prognostic value of baseline C-reactive protein in diffuse large B-cell lymphoma: a systematic review and meta-analysis","volume":"12","author":"Huang","year":"2023","journal-title":"Transl. Cancer Res."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107496_b0140","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1158\/2159-8290.CD-11-0206","article-title":"Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents","volume":"2","author":"Birkbak","year":"2012","journal-title":"Cancer Discov."},{"issue":"10","key":"10.1016\/j.lungcan.2024.107496_b0145","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/bjc.2012.451","article-title":"Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer","volume":"107","author":"Abkevich","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2024.107496_b0150","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.18632\/oncotarget.13918","article-title":"Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS","volume":"8","author":"Kautto","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.lungcan.2024.107496_b0155","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/PAS.0000000000001187","article-title":"Clinicopathologic Features of CIC-NUTM1 Sarcomas, a New Molecular Variant of the Family of CIC-Fused Sarcomas","volume":"43","author":"Le Loarer","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"issue":"20","key":"10.1016\/j.lungcan.2024.107496_b0160","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1158\/1078-0432.CCR-12-1153","article-title":"Clinicopathologic features and long-term outcomes of NUT midline carcinoma","volume":"18","author":"Bauer","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107496_b0165","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/08880018.2017.1363839","article-title":"Pediatric NUT-midline carcinoma: Therapeutic success employing a sarcoma based multimodal approach","volume":"34","author":"Storck","year":"2017","journal-title":"Pediatr. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.lungcan.2024.107496_b0170","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/pbc.20755","article-title":"Successful treatment of a child with t(15;19)-positive tumor","volume":"49","author":"Mertens","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"issue":"8","key":"10.1016\/j.lungcan.2024.107496_b0175","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2169\/internalmedicine.7741-21","article-title":"Complete Response Induced by Concurrent Chemoradiotherapy in a Patient with NUT Carcinoma","volume":"61","author":"Muramatsu","year":"2022","journal-title":"Intern. Med."},{"key":"10.1016\/j.lungcan.2024.107496_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijscr.2023.108015","article-title":"Case report on the role of aggressive palliative surgery in lung NUT carcinoma after induction chemoimmunotherapy","volume":"105","author":"Alcasid","year":"2023","journal-title":"Int. J. Surg. Case Rep."},{"issue":"9","key":"10.1016\/j.lungcan.2024.107496_b0185","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/oncolo\/oyad177","article-title":"Prolonged Survival of NUT Midline Carcinoma and Current Approaches to Treatment","volume":"28","author":"Kaplan","year":"2023","journal-title":"Oncologist"},{"issue":"23","key":"10.1016\/j.lungcan.2024.107496_b0190","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1002\/cncr.30242","article-title":"Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck","volume":"122","author":"Chau","year":"2016","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.lungcan.2024.107496_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101184","article-title":"Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitors","volume":"14","author":"Riess","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.lungcan.2024.107496_b0200","article-title":"Immunotherapy and Targeting the Tumor Microenvironment: Current Place and New Insights in Primary Pulmonary NUT Carcinoma","volume":"11","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"issue":"7964","key":"10.1016\/j.lungcan.2024.107496_b0205","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41586-023-06054-z","article-title":"Pan-cancer whole-genome comparison of primary and metastatic solid tumours","volume":"618","author":"Martinez-Jimenez","year":"2023","journal-title":"Nature"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224000291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224000291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:07:19Z","timestamp":1759237639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500224000291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":41,"alternative-id":["S0169500224000291"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107496","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107496"}}